This invention relates to the field of medical leads, and more specifically to an implantable lead.
Leads implanted in or about the heart have been used to reverse certain life threatening arrhythmia, or to stimulate contraction of the heart. Electrical energy is applied to the heart via the leads to return the heart to normal rhythm. Leads have also been used to sense in the atrium or ventricle of the heart and to deliver pacing and defibrillation pulses to the atrium or ventricle.
Permanent transvenous pacing is performed using a lead positioned within one or more chambers of the heart. One or more leads may be positioned in the ventricle or in the atrium through a subclavian vein, and the lead terminal pins are attached to a pacemaker which is implanted subcutaneously. One approach to heart pacing is to place an electrode in the apex of the right ventricle. The lead is held in place either passively or actively using a helix, for example.
Another approach is to place the electrode against the high ventricular septum or outflow tract. However, current leads require a lead placed with the electrode in such a position to be actively fixated. This possibly may result in trauma to the heart from cyclical heart motion, micro-dislodgement, and relatively higher pacing thresholds.
A lead body configured into a preformed J-shape. The lead includes a pacing electrode coupled to an intermediate portion of the lead body located distally from a bottom of the pre-formed J-shape. The lead is adapted to be placed within a heart in a J-shaped configuration with the electrode positioned against a ventricular septum or a right ventricular outflow tract such that at least a portion of the distal end of the lead body is located within a pulmonary artery. In one embodiment, the distal end of the lead is configured to be passively fixated within the pulmonary artery.
Another aspect includes a lead body wherein a section of the intermediate portion of the lead body is less stiff than adjacent sections of the lead body. The lead includes a pacing electrode coupled to the intermediate portion of the lead body and located distally from the less stiff section. The lead is adapted to be placed within a heart in a J-shaped configuration with the less stiff section near a bottom of the J-shape such that the electrode is positioned proximate a ventricular septum or a right ventricular outflow tract and at least a portion of the distal end of the lead body is fixated within a pulmonary artery.
Another aspect includes a method including inserting the lead through a right ventricle and into a pulmonary artery such that the pacing electrode is proximate a ventricular septum or a ventricular outflow tract and the distal end is within the pulmonary artery.
One or more embodiments of the methods and apparatus disclosed herein can result in lower pacing thresholds, better electrode contact, prevent micro-dislodgement of pacing/sensing electrodes, offer better reliability, and ease of implanting and explanting the lead.
In the following detailed description, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that other embodiments may be utilized and that structural changes may be made without departing from the scope of the present invention. Therefore, the following detailed description is not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.
Pulse generator 110 can be implanted in a surgically-formed pocket in a patient's chest or other desired location. Pulse generator 110 generally includes electronic components to perform signal analysis and processing, and control. Pulse generator 110 can include a power supply such as a battery, a capacitor, and other components housed in a case. The device can include microprocessors to provide processing, evaluation, and to determine and deliver electrical shocks and pulses of different energy levels and timing for ventricular defibrillation, cardioversion, and pacing to heart 10 in response to cardiac arrhythmia including fibrillation, tachycardia, and bradycardia.
In one embodiment, lead 100 is designed for septal placement of the pacing electrode with a distal end of the lead located in the pulmonary artery. Lead 100 can pace and sense at the His bundle/septum/outflow tract, and there is less trauma than caused by active fixation.
In one embodiment, lead 100 includes a lead body 105 extending from a proximal end 107 to a distal end 109 and having an intermediate portion 111. Lead 100 includes one or more conductors, such as coiled conductors, to conduct energy from pulse generator 110 to heart 10, and also to receive signals from the heart. The lead further includes outer insulation 112 to insulate the conductor. The conductors are coupled to one or more electrodes, such as electrodes 124 and 126. Lead terminal pins are attached to pulse generator 110. The system can include a unipolar system with the case acting as an electrode or a bipolar system.
In one embodiment, lead 100 is adapted for septal placement of one or more of the electrodes 124 and 126 while utilizing pulmonary artery 22 for lead fixation. Lead 100 can pace and sense at the interventricular septum 18 or ventricular outflow tract 20. For example, in one embodiment electrodes 124 and 126 are coupled to intermediate portion 111 of the lead. Electrodes 124 and 126 can be pacing/sensing electrodes, such as ring electrodes, designed to deliver a pacing pulse of approximately 0.5 volts at 0.1 milliseconds to approximately 15 volts at 2.0 milliseconds to septum 18 in a bipolar pulsing system. Electrodes 124 and 126 are proximal from distal end 109 and are located on the lead to sense or pace high on the ventricular septum (above apex 17), or in the ventricular outflow tract when the lead is implanted. Advantageously, lead 100 allows such a high placement while not requiring active fixation.
When inserted in the heart and positioned such that electrodes 124 and 126 are against ventricular septum 18, some leads require active fixation. However, active fixation can cause repeated trauma to the endocardial tissue because of the cyclical motion of the heart, and thus may have possible micro-dislodgement and increase defibrillation and pacing thresholds.
In one embodiment, lead body 105 including a preformed, biased J-shape 120 formed in the intermediate portion 111 of the lead body. J-shape 120 is located such that electrode 124 and 126 are located distally from a bottom 122 of the pre-formed J-shape 120. Pre-formed J-shape 120 can be in either 2D or 3D. J-shaped portion 120 of lead 100 allows for better septal/electrode contact. To pre-form the lead, the lead can be manufactured such that it is biased in the J-shape. Thus, the lead naturally reverts to the J-shape when it is implanted. For example, the lead body can be formed in the pre-biased shape or the conductor coils can be formed in the pre-biased shape to bias the lead body into the J-shape. When implanted, the bottom 122 of the J-shape 120 is within the right ventricle 16 and electrodes 124 and 126 are positioned proximate ventricular septum 18 above apex 17, or positioned in right ventricular outflow tract 20 such that at least a portion of the distal end 109 of the lead body is located within a pulmonary artery 22. The pre-formed J-lead design enhances the septal electrode stability and contact. It can help result in low pacing thresholds because of better electrode contacts.
In one embodiment, at least a portion of lead 100 can include an anti-thrombosis coating 140, such as Hypren or polyethleneglycol for example. Coating 140 can be placed on the lead, for example on one or more of the electrodes, or on the distal portion of the lead, or on other segments of the lead.
In one embodiment, lead 100 can include a sensor 150, such as a cardiac output sensor, mounted to the intermediate portion of the lead 100. Sensor 150 can be implanted to such a location within the outflow tract 20 to monitor cardiac output. In one example, cardiac output monitoring sensor 150 can be placed proximate the distal end of the lead to be placed within the pulmonary artery. Sensor 150 can be coupled to pulse generator 110 through a conductor.
In one embodiment, sensor 150 can be a flow speed sensor, allowing the system to know how fast the blood is going through the artery. For example, sensor 150 can be a metal ring, coil, or fin. Such a component would have resistance properties such that if a pulse of energy was sent through the component, the component would heat up, which would in turn increase the electrical resistance of the component. The electrical resistance could be monitored over time to determine how it changes as the blood flow going past it cools it down to blood temperature. The faster the blood flow, the faster the component will cool down and hence the faster the resistance should drop. This cool down or resistance change can be correlated to the blood flow. In other embodiments, sensor 150 can be a pressure sensor. In some embodiments, sensor 150 can include a CO2 or O2 sensor.
In these embodiments, sensor 150 can be used to determine blood flow to allow the position of electrodes 124 and 126 to be optimized. For example, the cardiac output can be used to change the position of the electrode either during or after implantation. Moreover, sensor 150 can be utilized during therapy. For example, if the flow rate goes down the system can deliver a pulse or increase the voltage of the pulse.
In some embodiments, lead 100 can be configured to allow both a stylet or catheter delivery. For example, an opening can be left through the middle of the lead to allow a stylet to be used.
In one embodiment, distal end 109 is adapted for being passively fixated within a pulmonary artery. For example, as will be discussed below, a pre-formed biased distal portion 109 can be provided. In some embodiments, to be discussed below, an active fixation technique is utilized. Some embodiments utilize neither passive nor active fixation, relying on the J-shape 120 and gravity to hold the electrodes 124 and 126 in place against the septum.
In various embodiments, pre-formed bias shape 130 of distal end 109 can include a curved shape such as an S-shape, a C-shape, a J-shape, an O-shape, and other non-linear shapes adapted for contacting one or sides of the pulmonary artery to provide sufficient fixation of the lead. Lead 100 is more reliable because the lead is easier to implant and explant because of the passive fixation which is allowed by the shape of the distal portion of lead 100. For example, passive fixation allows for easier adjustment of electrode placement, and is easier to explant. Moreover, there is less trauma or perforation to endocardium tissue, which can yield lower pacing thresholds. Also, there is less trauma to the septal/outflow tract caused by active fixation at the septal/outflow tract location.
In one embodiment, lead 200 includes a section 210 of the intermediate section 211 of the lead which is less stiff than adjacent sections 212 and 216 of the lead body. Lest stiff section 210 is located proximally from electrodes 124 and 126. When lead 200 is positioned in the heart with distal portion 209 in the pulmonary artery, the soft, or less stiff section 210 allows the lead to naturally fall into place and contact the septum due to gravity. Lead 200 is adapted to be placed within a heart in a J-shaped configuration with the less stiff section near a bottom 218 of the J-shape such that electrodes 124 and 126 are positioned proximate ventricular septum 18 or right ventricular outflow tract 20 and at least a portion of the distal end 209 of the lead body is located within a pulmonary artery. The less stiff section 210 provides means on the lead body for reducing any forces caused by heart motion to be transferred to a site of the electrode.
In one embodiment, the less stiff section 210 includes a different, more pliable material than the material of adjacent sections 212 and 216. Again, when the lead is positioned in the heart, the soft segment allows the lead to naturally fall into place and contact the septum due to gravity. The less stiff section 210 enhances the septal electrode stability and contact. Also, it reduces or eliminates the forces and motion (caused by heart motion) transferred to the site of the septal pacing electrodes 124 and 126. This can result in lower pacing thresholds because of better electrode contact.
In this example, as S-shaped passive fixation configuration is provided for distal end 109. In other embodiments, passive techniques as shown above in
In one example use of one or more of the leads discussed herein, the lead is inserted through the right ventricle and into the pulmonary artery using a guiding catheter or a stylet. The lead is positioned until the distal end of the lead is in the pulmonary artery and electrodes are positioned against the septum. The lead can then be fixated there by one of the passive techniques discussed above. When the pulse generator detects a need for pacing, the pulse is delivered via electrodes 124 or 126 in either a bipolar or unipolar system.
It is understood that the above description is intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application is a continuation of U.S. patent application Ser. No. 10/325,433, filed on Dec. 19, 2002 now U.S. Pat. No. 7,392,094, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3209305 | Bruckner et al. | Sep 1965 | A |
3974834 | Kane | Aug 1976 | A |
3995623 | Blake et al. | Dec 1976 | A |
4046151 | Rose | Sep 1977 | A |
4307928 | Petlock, Jr. | Dec 1981 | A |
4332259 | McCorkle, Jr. | Jun 1982 | A |
4402328 | Doring | Sep 1983 | A |
4458677 | McCorkle, Jr. | Jul 1984 | A |
4471777 | McCorkle, Jr. | Sep 1984 | A |
4488561 | Doring | Dec 1984 | A |
4576162 | McCorkle | Mar 1986 | A |
4582056 | McCorkle, Jr. | Apr 1986 | A |
4595009 | Leinders | Jun 1986 | A |
4627439 | Harris | Dec 1986 | A |
4632125 | Webler et al. | Dec 1986 | A |
4641656 | Smits | Feb 1987 | A |
4643201 | Stokes | Feb 1987 | A |
4759378 | Swendson et al. | Jul 1988 | A |
4957111 | Millar | Sep 1990 | A |
4986270 | Cohen | Jan 1991 | A |
4991603 | Cohen et al. | Feb 1991 | A |
4998975 | Cohen et al. | Mar 1991 | A |
5000190 | Petre | Mar 1991 | A |
5014696 | Mehra | May 1991 | A |
5029585 | Lieber et al. | Jul 1991 | A |
5044375 | Bach et al. | Sep 1991 | A |
5103821 | King | Apr 1992 | A |
5107834 | Ideker et al. | Apr 1992 | A |
5144960 | Mehra et al. | Sep 1992 | A |
5176137 | Erickson et al. | Jan 1993 | A |
5217318 | Peppel | Jun 1993 | A |
5224491 | Mehra | Jul 1993 | A |
5226427 | Buckberg et al. | Jul 1993 | A |
5246014 | Williams et al. | Sep 1993 | A |
5314462 | Heil et al. | May 1994 | A |
5336252 | Cohen | Aug 1994 | A |
5342413 | Hirschberg et al. | Aug 1994 | A |
5353800 | Pohndorf et al. | Oct 1994 | A |
5387233 | Alferness et al. | Feb 1995 | A |
5387234 | Hirschberg | Feb 1995 | A |
5403351 | Saksena | Apr 1995 | A |
5405374 | Stein | Apr 1995 | A |
5409469 | Schaerf | Apr 1995 | A |
5411527 | Alt | May 1995 | A |
5423772 | Lurie et al. | Jun 1995 | A |
5423806 | Dale et al. | Jun 1995 | A |
5423865 | Bowald et al. | Jun 1995 | A |
5433729 | Adams et al. | Jul 1995 | A |
5433742 | Willis | Jul 1995 | A |
5447519 | Peterson | Sep 1995 | A |
5476498 | Ayers | Dec 1995 | A |
5476499 | Hirschberg | Dec 1995 | A |
5476500 | Fain et al. | Dec 1995 | A |
5531779 | Dahl et al. | Jul 1996 | A |
5545204 | Cammilli et al. | Aug 1996 | A |
5571159 | Alt | Nov 1996 | A |
5609621 | Bonner | Mar 1997 | A |
5628779 | Bornzin et al. | May 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5639276 | Weinstock et al. | Jun 1997 | A |
5643338 | Bornzin et al. | Jul 1997 | A |
5643580 | Subramaniam | Jul 1997 | A |
5649974 | Nelson et al. | Jul 1997 | A |
5674217 | Wahlstrom et al. | Oct 1997 | A |
5674272 | Bush et al. | Oct 1997 | A |
5683447 | Bush et al. | Nov 1997 | A |
5693081 | Fain et al. | Dec 1997 | A |
5697965 | Griffin, III | Dec 1997 | A |
5713867 | Morris | Feb 1998 | A |
5728140 | Salo et al. | Mar 1998 | A |
5769858 | Pearson et al. | Jun 1998 | A |
5772693 | Brownlee | Jun 1998 | A |
5788647 | Eggers | Aug 1998 | A |
5800498 | Obino et al. | Sep 1998 | A |
5803928 | Tockman et al. | Sep 1998 | A |
5843117 | Alt et al. | Dec 1998 | A |
5843141 | Bischoff et al. | Dec 1998 | A |
5851226 | Skubitz et al. | Dec 1998 | A |
5861023 | Vachon | Jan 1999 | A |
5871530 | Williams et al. | Feb 1999 | A |
5897584 | Herman | Apr 1999 | A |
5902331 | Bonner et al. | May 1999 | A |
5922014 | Warman et al. | Jul 1999 | A |
5925073 | Chastain et al. | Jul 1999 | A |
5932360 | Hazlitt et al. | Aug 1999 | A |
5994444 | Trescony et al. | Nov 1999 | A |
6006122 | Smits | Dec 1999 | A |
6021354 | Warman et al. | Feb 2000 | A |
6038472 | Williams et al. | Mar 2000 | A |
6043273 | Duhaylongsod | Mar 2000 | A |
6055457 | Bonner | Apr 2000 | A |
6076014 | Alt | Jun 2000 | A |
6093982 | Kroll | Jul 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6122553 | Idekar et al. | Sep 2000 | A |
6129750 | Tockman et al. | Oct 2000 | A |
6132390 | Cookston et al. | Oct 2000 | A |
6159237 | Alt et al. | Dec 2000 | A |
6161029 | Spreigl et al. | Dec 2000 | A |
6178355 | Williams et al. | Jan 2001 | B1 |
6223087 | Williams | Apr 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6256541 | Heil et al. | Jul 2001 | B1 |
6363286 | Zhu et al. | Mar 2002 | B1 |
6363287 | Brabee et al. | Mar 2002 | B1 |
6445954 | Olive et al. | Sep 2002 | B1 |
6463323 | Conrad-Vlasak et al. | Oct 2002 | B1 |
6501992 | Belden et al. | Dec 2002 | B1 |
6532378 | Saksena et al. | Mar 2003 | B2 |
6643546 | Mathis et al. | Nov 2003 | B2 |
6718211 | Smits | Apr 2004 | B2 |
6741893 | Smits | May 2004 | B2 |
6760619 | Helland et al. | Jul 2004 | B1 |
6882886 | Witte et al. | Apr 2005 | B1 |
7238883 | Zarembo | Jul 2007 | B2 |
7392094 | Zhang et al. | Jun 2008 | B2 |
7512440 | Ortega et al. | Mar 2009 | B2 |
7555351 | Zhang et al. | Jun 2009 | B2 |
7890188 | Zhang et al. | Feb 2011 | B2 |
20010020179 | Audoglio | Sep 2001 | A1 |
20010031987 | Saksena et al. | Oct 2001 | A1 |
20020049485 | Smits | Apr 2002 | A1 |
20020065544 | Smits | May 2002 | A1 |
20040054390 | Zarembo et al. | Mar 2004 | A1 |
20040122496 | Zhang et al. | Jun 2004 | A1 |
20040122497 | Zhang et al. | Jun 2004 | A1 |
20040122498 | Zhang et al. | Jun 2004 | A1 |
20040147994 | Zhang et al. | Jul 2004 | A1 |
20040260374 | Zhang et al. | Dec 2004 | A1 |
20040260375 | Zhang et al. | Dec 2004 | A1 |
20050149155 | Scheiner et al. | Jul 2005 | A1 |
20050149156 | Libbus et al. | Jul 2005 | A1 |
20050228469 | Zarembo et al. | Oct 2005 | A1 |
20060089694 | Zhang et al. | Apr 2006 | A1 |
20070205014 | Zarembo | Sep 2007 | A1 |
20070299492 | Zhang et al. | Dec 2007 | A1 |
20080262586 | Zhang et al. | Oct 2008 | A1 |
20090264974 | Zhang et al. | Oct 2009 | A1 |
Number | Date | Country |
---|---|---|
3-168162 | Jul 1992 | JP |
09-508054 | Aug 1997 | JP |
2001-522287 | Nov 2001 | JP |
2002-126095 | May 2002 | JP |
WO 9615665 | May 1996 | WO |
WO 9848896 | Nov 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20080262586 A1 | Oct 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10325433 | Dec 2002 | US |
Child | 12144247 | US |